Patterns of survival in multiple myeloma: A population-based study of patients diagnosed in Sweden from 1973 to 2003 Academic Article uri icon

Overview

MeSH Major

  • Multiple Myeloma

abstract

  • One-year MM survival has increased for all age groups during the last decades; 5-year and 10-year MM survival has increased in younger patients (younger than 60 to 70 years). High-dose melphalan with subsequent autologous stem-cell transplantation, thalidomide, and a continuous improvement in supportive care measures are probably the most important factors contributing to this finding. New effective agents with a more favorable toxicity profile are needed to improve survival further, particularly in the elderly.

publication date

  • May 20, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2006.09.0100

PubMed ID

  • 17420512

Additional Document Info

start page

  • 1993

end page

  • 9

volume

  • 25

number

  • 15